Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Epilepsy & Behavior : E&B
|
April 5, 2022
Evaluation of one-year effectiveness of clobazam as an add-on therapy to anticonvulsant monotherapy in participants with epilepsy having uncontrolled seizure episodes: An Indian experience
Parthasarathy Satishchandra, Chaturbhuj Rathore, Anirudha Apte, et al.
Clinical and Molecular Hepatology
|
April 11, 2024
Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment
Do Seon Song, Hee Yeon Kim, Young Kul Jung, et al.
Epilepsy & Behavior : E&B
|
October 17, 2025
Effectiveness and safety of clobazam as add-on therapy in children after the failure of first antiseizure medicine: a sub-analysis of the ADD-ON study
Parthasarathy Satishchandra, Chaturbhuj Rathore, Abhishek Kumar, et al.
Journal of Medicinal Chemistry
|
August 2, 2018
Design, Synthesis, and SAR of C-3 Benzoic Acid, C-17 Triterpenoid Derivatives. Identification of the HIV-1 Maturation Inhibitor 4-((1 R,3a S,5a R,5b R,7a R,11a S,11b R,13a R,13b R)-3a-((2-(1,1-Dioxidothiomorpholino)ethyl)amino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1 H-cyclopenta[ a]chrysen-9-yl)benzoic Acid (GSK3532795, BMS-955176)
Alicia Regueiro-Ren, Jacob J Swidorski, Zheng Liu, et al.
ACS Medicinal Chemistry Letters
|
May 26, 2015
Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid Tumors
Ashvinikumar V Gavai, Claude Quesnelle, Derek Norris, et al.
Hepatology International
|
May 26, 2023
Asia-Pacific association for study of liver guidelines on management of ascites in liver disease
Virendra Singh, Arka De, Rohit Mehtani, et al.
Hepatology International
|
October 5, 2021
'First week' is the crucial period for deciding living donor liver transplantation in patients with acute-on-chronic liver failure
Ashok Choudhury, Rajan Vijayaraghavan, Rakhi Maiwall, et al.
Hepatology International
|
April 5, 2024
APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure
Rakhi Maiwall, Satender Pal Singh, Paolo Angeli, et al.
The American Journal of Gastroenterology
|
July 17, 2024
Impact of Diabetes, Drug-Induced Liver Injury, and Sepsis on Outcomes in Metabolic Dysfunction Associated Fatty Liver Disease-Related Acute-on-Chronic Liver Failure
Ashish Kumar, Anil Arora, Ashok Choudhury, et al.
Hepatology International
|
October 25, 2025
Diabetes mellitus is linked to higher mortality in alcohol-related acute-on-chronic liver failure
Ashish Kumar, Anil Arora, Praveen Sharma, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Epilepsy & Behavior : E&B
|
April 5, 2022
Evaluation of one-year effectiveness of clobazam as an add-on therapy to anticonvulsant monotherapy in participants with epilepsy having uncontrolled seizure episodes: An Indian experience
Parthasarathy Satishchandra, Chaturbhuj Rathore, Anirudha Apte, et al.
Clinical and Molecular Hepatology
|
April 11, 2024
Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment
Do Seon Song, Hee Yeon Kim, Young Kul Jung, et al.
Epilepsy & Behavior : E&B
|
October 17, 2025
Effectiveness and safety of clobazam as add-on therapy in children after the failure of first antiseizure medicine: a sub-analysis of the ADD-ON study
Parthasarathy Satishchandra, Chaturbhuj Rathore, Abhishek Kumar, et al.
Journal of Medicinal Chemistry
|
August 2, 2018
Design, Synthesis, and SAR of C-3 Benzoic Acid, C-17 Triterpenoid Derivatives. Identification of the HIV-1 Maturation Inhibitor 4-((1 R,3a S,5a R,5b R,7a R,11a S,11b R,13a R,13b R)-3a-((2-(1,1-Dioxidothiomorpholino)ethyl)amino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1 H-cyclopenta[ a]chrysen-9-yl)benzoic Acid (GSK3532795, BMS-955176)
Alicia Regueiro-Ren, Jacob J Swidorski, Zheng Liu, et al.
ACS Medicinal Chemistry Letters
|
May 26, 2015
Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid Tumors
Ashvinikumar V Gavai, Claude Quesnelle, Derek Norris, et al.
Hepatology International
|
May 26, 2023
Asia-Pacific association for study of liver guidelines on management of ascites in liver disease
Virendra Singh, Arka De, Rohit Mehtani, et al.
Hepatology International
|
October 5, 2021
'First week' is the crucial period for deciding living donor liver transplantation in patients with acute-on-chronic liver failure
Ashok Choudhury, Rajan Vijayaraghavan, Rakhi Maiwall, et al.
Hepatology International
|
April 5, 2024
APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure
Rakhi Maiwall, Satender Pal Singh, Paolo Angeli, et al.
The American Journal of Gastroenterology
|
July 17, 2024
Impact of Diabetes, Drug-Induced Liver Injury, and Sepsis on Outcomes in Metabolic Dysfunction Associated Fatty Liver Disease-Related Acute-on-Chronic Liver Failure
Ashish Kumar, Anil Arora, Ashok Choudhury, et al.
Hepatology International
|
October 25, 2025
Diabetes mellitus is linked to higher mortality in alcohol-related acute-on-chronic liver failure
Ashish Kumar, Anil Arora, Praveen Sharma, et al.
Page
of 8